Skip to main content
SpringerLink
Log in
Book cover

Lymphoma and Leukemia of the Nervous System pp 313–328Cite as

Neurological Complications of Acute and Chronic Leukemia

  • Chapter
  • First Online:

  • 1011 Accesses

Abstract

Leukemia affects both the central and peripheral nervous system. Neurological complications are a consequence of direct leukemic infiltration, as occurs with leukemic meningitis, anti-leukemic treatment (thrombocytopenic or DIC-related intracranial hemorrhage, steroid myopathy, vinca alkaloid peripheral neuropathy, posterior reversible encephalopathy syndrome, multifocal necrotizing leukoencephalopathy), or immune compromise (Herpes zoster shingles or Aspergillus meningitis).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Xie Y, Davies SM, Xiang Y et al (2004) Trends in leukemia incidence and survival in the United States (1973–1998). Cancer 97(9):2229–2235

    Article  Google Scholar 

  2. Hoelzer D, Gokbuget N, Ottmann O et al (2002) Acute lymphoblastic leukemia. Hematology 1:162–171

    Article  Google Scholar 

  3. Pui CH, Carroll WL, Meshinchi S, Arceci RJ (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J Clin Oncol 29(5):551–565

    Google Scholar 

  4. Recht L, Mrugala M (2003) Neurologic complications of hematologic neoplasms. Neurol Clin N Am 21:87–105

    Google Scholar 

  5. Meyer RJ, Ferreira PP, Cuttner J et al (1980) Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study. Am J Med 68:691–694

    Article  PubMed  CAS  Google Scholar 

  6. Teshima T, Akashi K, Shibuka T et al (1990) Central nervous system involvement in adult T-cell leukemia/lymphoma. Cancer 65:327–332

    Article  PubMed  CAS  Google Scholar 

  7. Kim H, Lee J-H, Choi S-J et al (2004) Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients. Haematologica 89:622–624

    PubMed  Google Scholar 

  8. Kawanami T, Kurita K, Yamakawa M et al (2002) Cerebrovascular disease in acute leukemia: a clinicopathological study of 14 patients. Intern Med 41(12):1130–1134

    Article  PubMed  Google Scholar 

  9. Sostak P, Padovan CS, Yousry TA et al (2003) Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60:842–848

    PubMed  CAS  Google Scholar 

  10. Bower JH, Hammack JE, McDonnell SK, Tefferi A (1997) The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 48:407–412

    PubMed  CAS  Google Scholar 

  11. Cramer SC, Glaspy JA, Efird JT, Louis DN (1996) Chronic lymphocytic leukemia and the central nervous system: A clinical and pathological study. Neurology 46:19–25

    PubMed  CAS  Google Scholar 

  12. Plotkin SR, Wen PY (2003) Neurologic complications of cancer therapy. Neurol Clin N Am 21:279–318

    Google Scholar 

  13. Cortes J (2001) Central nervous system involvement in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 15:145–162

    Article  PubMed  CAS  Google Scholar 

  14. Wolk RW, Masse SR, Conklin R, Freireich EJ (1974) The incidence of central nervous system leukemia in adults with acute leukemia. Cancer 33:863–871

    Article  PubMed  CAS  Google Scholar 

  15. Stewart DJ, Keating MJ, McCredie KB et al (1981) Natural history of central nervous system acute leukemia in adults. Cancer 47:184–196

    Article  PubMed  CAS  Google Scholar 

  16. Rachmani R, Avidor A, Youkla P et al (1998) Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with alpha-interferon-A report of two successfully treated patients. Acta Haematol 100:204–206

    Article  PubMed  CAS  Google Scholar 

  17. Byrnes JJ, Baquerizo H, Gonzalez GT et al (1986) Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia. Am J Hematol 21:299–304

    Article  PubMed  CAS  Google Scholar 

  18. Chen C-Y, Zimmerman RA, Faro S et al (1996) Childhood Leukemia: central nervous system abnormalities during and after treatment. AJNR 17:295–310

    PubMed  CAS  Google Scholar 

  19. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494

    Article  PubMed  CAS  Google Scholar 

  20. Shin RK, Stern JW, Janss AJ et al (2001) Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 56:388–391

    PubMed  CAS  Google Scholar 

  21. Lavigne CM, Shrier DA, Ketkar M, Powers JM (2004) Tacrolimus leukoencephalopathy: a neuropathological confirmation. Neurology 2:1132–1133

    Google Scholar 

  22. Lamy C, Oppenheim C, Meder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89–96

    PubMed  CAS  Google Scholar 

  23. Anders KH, Becker SP, Holden JK et al (1993) Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases. Hum Pathol 24(8):897–904

    Article  PubMed  CAS  Google Scholar 

  24. Surapaneni UR, Cortes JE, Thomas D et al (2002) Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia. Cancer 94(3):773–780

    Article  PubMed  Google Scholar 

  25. Cash J, Fehir KM, Pollack MS (1987) Meningeal involvement in early stage chronic lymphocytic leukemia. Cancer 59:798–800

    Article  PubMed  CAS  Google Scholar 

  26. Dekker AW, Elderson A, Punt K, Sixma JJ (1985) Meningeal involvement in patients with acute non-lymphocytic leukemia. Cancer 985(56):2078–2082

    Article  Google Scholar 

  27. Kaplan JG, DeSouza TG, Farkash A et al (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9:225–229

    Article  PubMed  CAS  Google Scholar 

  28. Chamberlain M (1996) Leptomeningeal metastases. In: Levin V (ed) Cancer in the Nervous System. Churchill Livingstone, New York, NY, pp 282–290

    Google Scholar 

  29. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25(2):103–119

    Article  PubMed  CAS  Google Scholar 

  30. Chamberlain MC (1998) Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 37:271–284

    Article  PubMed  CAS  Google Scholar 

  31. Kantarjian HM, Walters RS, Smith TL et al (1988) Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood 72:1784–1789

    PubMed  CAS  Google Scholar 

  32. Kantarjian HM, Smith T, Estey E et al (1992) Prognostic significance of elevated serum beta 2-microglobulin levels in acute lymphocytic leukemia. Am J Med 93:599–604

    Article  PubMed  CAS  Google Scholar 

  33. Ravandi F, Cortes J, Estrov Z et al (2002) CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 26:643–649

    Article  PubMed  CAS  Google Scholar 

  34. Kantarijian HM, O’Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult a cute lymphocytic leukemia. J Clin Oncol 18:547–561

    Google Scholar 

  35. Mavlight GM, Stuckey SE, Cabanillas FF et al (1980) Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med. 303:718–722

    Article  PubMed  CAS  Google Scholar 

  36. Kersten MJ, Evers LM, Dellemijn PL et al (1996) Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 87:1985–1999

    PubMed  CAS  Google Scholar 

  37. Burger B, Zimmermann M, Mann G et al (2003) Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 21(2):184–188

    Article  PubMed  Google Scholar 

  38. Wasserstrom W, Glass J, Posner J (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors experience with 90 patients. Cancer 49:759–772

    Article  PubMed  CAS  Google Scholar 

  39. Van Oostenbrugge RJ, Twijnstra A (1999) Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 53:382–385

    PubMed  Google Scholar 

  40. Wasserstrom WR, Schwartz MK, Fleisher M et al (1981) Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Ann Clin Lab Sci 11(3):239–251

    PubMed  CAS  Google Scholar 

  41. Van Zanten AP, Twijnstra A, Hart AA et al (1986) Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. Clin Chim Acta 161(3):259–268

    Article  PubMed  Google Scholar 

  42. Klee GG, Tallman RD, Goellner JR et al (1986) Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 61(1):9–13

    PubMed  CAS  Google Scholar 

  43. Twijnstra A, van Zanten AP, Hart AA et al (1987) Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry 50(3):313–320

    Article  PubMed  CAS  Google Scholar 

  44. Twijnstra A, Ongerboer de VBW, van Zanten AP et al (1989) Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neurooncol 7(1):57–63

    Article  PubMed  CAS  Google Scholar 

  45. Chamberlain MC (1998) Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 50(4):1173–1175

    PubMed  CAS  Google Scholar 

  46. Garson JA, Coakham HB, Kemshead JT et al (1985) The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neurooncol 3(2):165–171

    Article  PubMed  CAS  Google Scholar 

  47. Boogerd W, Vroom TM, van Heerde P et al (1988) CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry 51(1):142–145

    Article  PubMed  CAS  Google Scholar 

  48. Van Oostenbrugge RJ, Hopman AH, Ramaekers FC et al (1998) In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis. J Neurooncol 38(2–3):127–133

    Article  PubMed  Google Scholar 

  49. Cibas ES, Malkin MG, Posner JB et al (1987) Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 88(5):570–577

    PubMed  CAS  Google Scholar 

  50. Biesterfeld S, Bernhard B, Bamborschke S et al (1993) DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol (Berl) 86(5):428–432

    Article  CAS  Google Scholar 

  51. Van Oostenbrugge RJ, Hopman AH, Arends JW et al (1998) The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 51(3):906–908

    PubMed  Google Scholar 

  52. Chamberlain M, Sandy A, Press G (1990) Leptomeningeal metastasis a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 40:435–438

    PubMed  CAS  Google Scholar 

  53. Gomori JM, Heching N, Siegal T (1998) Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging. J Neuro Oncol 36:55–60

    Article  CAS  Google Scholar 

  54. Sze G, Soletsky S, Bronen R et al (1989) MR imaging of the cranial meninges with emphasis on contrast enhancements and meningeal carcinomatosis. AJNR 10:965–975

    PubMed  CAS  Google Scholar 

  55. Chamberlain MC (1995) Comparative spine imaging in leptomeningeal metastases. Neurooncol 23:233–238

    Article  CAS  Google Scholar 

  56. Kramer E, Rafto S, Packer R et al (1991) Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children. Neurology 41:46–50

    PubMed  CAS  Google Scholar 

  57. Chamberlain M, Corey-Bloom J (1991) Leptomeningeal metastases Indium-DTPA CSF flow studies. Neurology 41:1765–1769

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Neurological Surgery, University of Washington, Seattle, WA, USA

    Marc C. Chamberlain

  2. Division of Neuro-Oncology, Department of Neurology, Fred Hutchinson Research Cancer Center, Seattle Cancer Care Alliance, Seattle, WA, 98109-1023, USA

    Marc C. Chamberlain

Authors
  1. Marc C. Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc C. Chamberlain .

Editor information

Editors and Affiliations

  1. , Stephen E. and Catherine Pappas Center f, Massachusetts General Hospital, Fruit St. 55, Boston, 02114, Massachusetts, USA

    Tracy Batchelor

  2. Dept. Neurology, Memorial Sloan-Kettering Cancer Center, York Ave. 1275, New York, 10021-6007, New York, USA

    Lisa M. DeAngelis

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Chamberlain, M.C. (2012). Neurological Complications of Acute and Chronic Leukemia. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_19

Download citation

Publish with us

Policies and ethics

Search

Navigation